drugset / Trial / NCT01684345
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
Phase 3
Terminated
200 enrolled
XOMA (US) LLC
Institut de Recherches Internationales Servier · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to evaluate the efficacy of gevokizumab in the treatment of active non-infectious intermediate, posterior, or pan- uveitis.
Timeline
- Start
- 2012-08
- Primary completion
- 2016-02
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | gevokizumab | Monoclonal antibody | — | Subcutaneous |